Improving the treatment of breathlessness – a phase III randomised, controlled trial of sustained release morphine for the symptomatic treatment of chronic refractory breathlessness. A Palliative Care Clinical Studies Collaborative study
Publication acknowledgement; not a spending or impact claim.
